Clinical Trial: Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: CLINICAL TRIAL TO DETERMINE THE EFFICACY AND SAFETY OF RAPAMYCIN IN ANGIOMYOLIPOMAS IN PATIENTS WITH TUBEROUS SCLEROSIS

Brief Summary: The purpose of this study is to determine whether rapamycin is safe and effective in the treatment of renal angiomyolipomas in patients with tuberousclerosis.